Your browser doesn't support javascript.
loading
Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy.
Conteduca, Vincenza; Caffo, Orazio; Scarpi, Emanuela; Sepe, Pierangela; Galli, Luca; Fratino, Lucia; Maines, Francesca; Chiuri, Vincenzo Emanuele; Santoni, Matteo; Zanardi, Elisa; Massari, Francesco; Toma, Ilaria; Lolli, Cristian; Schepisi, Giuseppe; Sbrana, Andrea; Kinspergher, Stefania; Cursano, Maria Concetta; Casadei, Chiara; Modonesi, Caterina; Santini, Daniele; Procopio, Giuseppe; De Giorgi, Ugo.
Afiliación
  • Conteduca V; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via Piero Maroncelli 40, 47014 Meldola, Italy.
  • Caffo O; Department of Oncology, Ospedale Santa Chiara, 38122 Trento, Italy.
  • Scarpi E; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via Piero Maroncelli 40, 47014 Meldola, Italy.
  • Sepe P; Medical Oncology Department, Fondazione Istituto Nazionale dei Tumori, 20133 Milano, Italy.
  • Galli L; Medical Oncology Unit 2, Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy.
  • Fratino L; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano, 33081 Aviano-Pordenone, Italy.
  • Maines F; Department of Oncology, Ospedale Santa Chiara, 38122 Trento, Italy.
  • Chiuri VE; Department of Oncology, Ospedale Vito Fazzi, 73100 Lecce, Italy.
  • Santoni M; Oncology Unit, Macerata Hospital, 62100 Macerata, Italy.
  • Zanardi E; Academic Unit of Medical Oncology, IRCCS San Martino Polyclinic Hospital, 16132 Genoa, Italy.
  • Massari F; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genoa, 16132 Genoa, Italy.
  • Toma I; Division of Oncology, S.Orsola-Malpighi Hospital, 40138 Bologna, Italy.
  • Lolli C; Clinical Oncology, Arcispedale Sant'Anna University Hospital, 44124 Ferrara, Italy.
  • Schepisi G; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via Piero Maroncelli 40, 47014 Meldola, Italy.
  • Sbrana A; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via Piero Maroncelli 40, 47014 Meldola, Italy.
  • Kinspergher S; Medical Oncology Unit 2, Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy.
  • Cursano MC; Department of Oncology, Ospedale Santa Chiara, 38122 Trento, Italy.
  • Casadei C; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via Piero Maroncelli 40, 47014 Meldola, Italy.
  • Modonesi C; Department of Medical Oncology, Campus Bio-Medico University of Rome, 00128 Rome, Italy.
  • Santini D; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via Piero Maroncelli 40, 47014 Meldola, Italy.
  • Procopio G; Ospedali Riuniti Padova SUD, 35043 Padua, Italy.
  • De Giorgi U; Department of Medical Oncology, Campus Bio-Medico University of Rome, 00128 Rome, Italy.
J Clin Med ; 9(6)2020 Jun 22.
Article en En | MEDLINE | ID: mdl-32580478

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Año: 2020 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Año: 2020 Tipo del documento: Article País de afiliación: Italia